Compile Data Set for Download or QSAR
Report error Found 17 Enz. Inhib. hit(s) with all data for entry = 10572
TargetGhrelin O-acyltransferase(Human)
Glaxosmithkline Intellectual Property Development

US Patent
LigandPNGBDBM550880(US11312709, Example 9b)
Affinity DataIC50: 50nMAssay Description:GOAT activity was assessed using a time-resolved fluorescence energy transfer (TR-FRET) assay in a 384-well format. His-tag human GOAT enzyme was in ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/6/2022
Entry Details
Go to US Patent

TargetGhrelin O-acyltransferase(Human)
Glaxosmithkline Intellectual Property Development

US Patent
LigandPNGBDBM550866(US11312709, Example 2a)
Affinity DataIC50: 50nMAssay Description:GOAT activity was assessed using a time-resolved fluorescence energy transfer (TR-FRET) assay in a 384-well format. His-tag human GOAT enzyme was in ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/6/2022
Entry Details
Go to US Patent

TargetGhrelin O-acyltransferase(Human)
Glaxosmithkline Intellectual Property Development

US Patent
LigandPNGBDBM550869(US11312709, Example 3b)
Affinity DataIC50: 50nMAssay Description:GOAT activity was assessed using a time-resolved fluorescence energy transfer (TR-FRET) assay in a 384-well format. His-tag human GOAT enzyme was in ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/6/2022
Entry Details
Go to US Patent

TargetGhrelin O-acyltransferase(Human)
Glaxosmithkline Intellectual Property Development

US Patent
LigandPNGBDBM550871(US11312709, Example 4b)
Affinity DataIC50: 50nMAssay Description:GOAT activity was assessed using a time-resolved fluorescence energy transfer (TR-FRET) assay in a 384-well format. His-tag human GOAT enzyme was in ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/6/2022
Entry Details
Go to US Patent

TargetGhrelin O-acyltransferase(Human)
Glaxosmithkline Intellectual Property Development

US Patent
LigandPNGBDBM50548075(CHEMBL4764363 | US11312709, Example 1a)
Affinity DataIC50: 50nMAssay Description:GOAT activity was assessed using a time-resolved fluorescence energy transfer (TR-FRET) assay in a 384-well format. His-tag human GOAT enzyme was in ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/6/2022
Entry Details
Go to US Patent

TargetGhrelin O-acyltransferase(Human)
Glaxosmithkline Intellectual Property Development

US Patent
LigandPNGBDBM550873(US11312709, Example 5b)
Affinity DataIC50: 50nMAssay Description:GOAT activity was assessed using a time-resolved fluorescence energy transfer (TR-FRET) assay in a 384-well format. His-tag human GOAT enzyme was in ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/6/2022
Entry Details
Go to US Patent

TargetGhrelin O-acyltransferase(Human)
Glaxosmithkline Intellectual Property Development

US Patent
LigandPNGBDBM550874(US11312709, Example 6a)
Affinity DataIC50: 50nMAssay Description:GOAT activity was assessed using a time-resolved fluorescence energy transfer (TR-FRET) assay in a 384-well format. His-tag human GOAT enzyme was in ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/6/2022
Entry Details
Go to US Patent

TargetGhrelin O-acyltransferase(Human)
Glaxosmithkline Intellectual Property Development

US Patent
LigandPNGBDBM550875(US11312709, Example 6b)
Affinity DataIC50: 50nMAssay Description:GOAT activity was assessed using a time-resolved fluorescence energy transfer (TR-FRET) assay in a 384-well format. His-tag human GOAT enzyme was in ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/6/2022
Entry Details
Go to US Patent

TargetGhrelin O-acyltransferase(Human)
Glaxosmithkline Intellectual Property Development

US Patent
LigandPNGBDBM550878(US11312709, Example 8)
Affinity DataIC50: 50nMAssay Description:GOAT activity was assessed using a time-resolved fluorescence energy transfer (TR-FRET) assay in a 384-well format. His-tag human GOAT enzyme was in ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/6/2022
Entry Details
Go to US Patent

TargetGhrelin O-acyltransferase(Human)
Glaxosmithkline Intellectual Property Development

US Patent
LigandPNGBDBM550877(US11312709, Example 7b)
Affinity DataIC50: 50nMAssay Description:GOAT activity was assessed using a time-resolved fluorescence energy transfer (TR-FRET) assay in a 384-well format. His-tag human GOAT enzyme was in ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/6/2022
Entry Details
Go to US Patent

TargetGhrelin O-acyltransferase(Human)
Glaxosmithkline Intellectual Property Development

US Patent
LigandPNGBDBM550879(US11312709, Example 9a)
Affinity DataIC50: 500nMAssay Description:GOAT activity was assessed using a time-resolved fluorescence energy transfer (TR-FRET) assay in a 384-well format. His-tag human GOAT enzyme was in ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/6/2022
Entry Details
Go to US Patent

TargetGhrelin O-acyltransferase(Human)
Glaxosmithkline Intellectual Property Development

US Patent
LigandPNGBDBM550868(US11312709, Example 3a)
Affinity DataIC50: 500nMAssay Description:GOAT activity was assessed using a time-resolved fluorescence energy transfer (TR-FRET) assay in a 384-well format. His-tag human GOAT enzyme was in ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/6/2022
Entry Details
Go to US Patent

TargetGhrelin O-acyltransferase(Human)
Glaxosmithkline Intellectual Property Development

US Patent
LigandPNGBDBM550870(US11312709, Example 4a)
Affinity DataIC50: 500nMAssay Description:GOAT activity was assessed using a time-resolved fluorescence energy transfer (TR-FRET) assay in a 384-well format. His-tag human GOAT enzyme was in ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/6/2022
Entry Details
Go to US Patent

TargetGhrelin O-acyltransferase(Human)
Glaxosmithkline Intellectual Property Development

US Patent
LigandPNGBDBM550872(US11312709, Example 5a)
Affinity DataIC50: 5.00E+3nMAssay Description:GOAT activity was assessed using a time-resolved fluorescence energy transfer (TR-FRET) assay in a 384-well format. His-tag human GOAT enzyme was in ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/6/2022
Entry Details
Go to US Patent

TargetGhrelin O-acyltransferase(Human)
Glaxosmithkline Intellectual Property Development

US Patent
LigandPNGBDBM550876(US11312709, Example 7a)
Affinity DataIC50: 5.00E+3nMAssay Description:GOAT activity was assessed using a time-resolved fluorescence energy transfer (TR-FRET) assay in a 384-well format. His-tag human GOAT enzyme was in ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/6/2022
Entry Details
Go to US Patent

TargetGhrelin O-acyltransferase(Human)
Glaxosmithkline Intellectual Property Development

US Patent
LigandPNGBDBM550867(US11312709, Example 2b)
Affinity DataIC50: 5.00E+3nMAssay Description:GOAT activity was assessed using a time-resolved fluorescence energy transfer (TR-FRET) assay in a 384-well format. His-tag human GOAT enzyme was in ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/6/2022
Entry Details
Go to US Patent

TargetGhrelin O-acyltransferase(Human)
Glaxosmithkline Intellectual Property Development

US Patent
LigandPNGBDBM550865(US11312709, Example 1b)
Affinity DataIC50: 5.00E+3nMAssay Description:GOAT activity was assessed using a time-resolved fluorescence energy transfer (TR-FRET) assay in a 384-well format. His-tag human GOAT enzyme was in ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/6/2022
Entry Details
Go to US Patent